Top Pharmaceuticals companies in Canada by Total Assets
Canada
# |
Name |
Total Assets |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 29.41 B
|
Dec. 31, 2023 | USD 122.81 | -2.58% |
|
Canada |
|
| 2 |
USD 27.35 B
|
Dec. 31, 2023 | USD 7.49 | 1.16% |
|
Canada |
|
| 3 |
USD 13.44 B
|
Dec. 31, 2023 | USD 17.23 | -0.99% |
|
Canada |
|
| 4 |
USD 4.22 B
|
May 31, 2024 | USD 1.18 | -0.37% |
|
Canada |
|
| 5 |
USD 1.49 B
|
Dec. 31, 2023 | USD 2.77 | -7.67% |
|
Canada |
|
| 6 |
USD 964.80 M
|
Dec. 31, 2023 | USD 39.65 | 3.66% |
|
Canada |
|
| 7 |
USD 959.90 M
|
March 31, 2024 | USD 2.23 | -6.78% |
|
Canada |
|
| 8 |
USD 862.83 M
|
Dec. 31, 2023 | USD 23.94 | 0.98% |
|
Canada |
|
| 9 |
USD 831.14 M
|
Dec. 31, 2023 | USD 13.41 | 0.42% |
|
Canada |
|
| 10 |
USD 713.37 M
|
Dec. 31, 2023 | USD 3.69 | 0.40% |
|
Canada |
|
| 11 |
USD 619.11 M
|
March 31, 2024 | USD 3.94 | -2.21% |
|
Canada |
|
| 12 |
USD 580.88 M
|
Dec. 31, 2023 | USD 13.62 | -2.44% |
|
Canada |
|
| 13 |
USD 548.06 M
|
Dec. 31, 2023 | USD 7.55 | -2.83% |
|
Canada |
|
| 14 |
USD 514.89 M
|
Dec. 31, 2023 | USD 30.84 | 0.81% |
|
Canada |
|
| 15 |
USD 311.17 M
|
Oct. 31, 2024 | USD 7.58 | -5.96% |
|
Canada |
|
| 16 |
USD 301.43 M
|
Sept. 30, 2024 | USD 1.53 | -2.45% |
|
Canada |
|
| 17 |
USD 253.90 M
|
Dec. 31, 2023 | USD 1.27 | -3.05% |
|
Canada |
|
| 18 |
USD 209.06 M
|
Dec. 31, 2023 | USD 2.70 | 2.33% |
|
Canada |
|
| 19 |
USD 174.96 M
|
Dec. 31, 2023 | USD 1.51 | -0.70% |
|
Canada |
|
| 20 |
USD 155.73 M
|
March 31, 2024 | USD 3.11 | 5.40% |
|
Canada |
|
| 21 |
USD 86.03 M
|
Dec. 31, 2023 | USD 9.40 | -4.39% |
|
Canada |
|
| 22 |
USD 77.77 M
|
Nov. 30, 2023 | USD 1.71 | 4.46% |
|
Canada |
|
| 23 |
USD 43.91 M
|
Dec. 31, 2023 | USD 7.26 | -2.32% |
|
Canada |
|
| 24 |
USD 27.35 M
|
Dec. 31, 2023 | USD 2.82 | -2.42% |
|
Canada |
|
| 25 |
USD 23.63 M
|
Dec. 31, 2023 | USD 0.94 | 1.68% |
|
Canada |
|
| 26 |
USD 19.37 M
|
Dec. 31, 2023 | USD 3.15 | -5.12% |
|
Canada |
|
| 27 |
USD 11.82 M
|
June 30, 2024 | USD 4.08 | -3.32% |
|
Canada |
|
| 28 |
USD 8.89 M
|
Sept. 30, 2023 | USD 1.59 | -8.09% |
|
Canada |
|
| 29 |
USD 8.87 M
|
Aug. 31, 2024 | USD 1.93 | -6.31% |
|
Canada |
|
| 30 |
USD 5.47 M
|
Dec. 31, 2023 | USD 1.25 | -0.34% |
|
Canada |
|
| 31 |
USD 4.32 M
|
Oct. 31, 2023 | USD 1.51 | -1.31% |
|
Canada |
Frequently Asked Questions
-
Which Pharmaceuticals company in Canada has the highest Total Assets ?
The Pharmaceuticals company in Canada with the highest Total Assets is Loblaw Companies Limited (Toronto Stock Exchange: L.TO) at USD 29.41 B.
-
Which Pharmaceuticals company in Canada has the lowest Total Assets ?
The Pharmaceuticals company in Canada with the lowest Total Assets is Clearmind Medicine Inc. (NasdaqCM: CMND) at USD 4.32 M.
-
What are the top 10 Pharmaceuticals companies in Canada by Total Assets ?
The top 10 Pharmaceuticals companies in Canada by Total Assets are Loblaw Companies Limited, Bausch Health Companies Inc., Bausch + Lomb Corporation, Tilray Brands, Inc., AbCellera Biologics Inc., Xenon Pharmaceuticals Inc., Canopy Growth Corporation, Jamieson Wellness Inc., Savaria Corporation and Knight Therapeutics Inc..
-
What are the bottom 10 Pharmaceuticals companies in Canada by Total Assets ?
The bottom 10 Pharmaceuticals companies in Canada by Total Assets are Clearmind Medicine Inc., XORTX Therapeutics Inc., Lexaria Bioscience Corp., Edesa Biotech, Inc., InMed Pharmaceuticals Inc., Achieve Life Sciences, Inc., Flora Growth Corp., Sunshine Biopharma, Inc., Profound Medical Corp. and Theratechnologies Inc..